$VKTX “My” Hypothetical perfect storm for maintenance. A VK2735 maintenance readout like this would be extremely difficult to dismiss 👇 ~ 17% weight loss at 21 weeks, with similar dose-response curves across cohorts ~ 22% weight loss at 33 weeks in the weekly control arm - Overall tolerability generally comparable to tirzepatide w/ rapid titration - 22.5 mg monthly AND 10 mg every other week also maintains weight neutrality Success in the maintenance cohorts would also strongly argue against an early plateau/tachyphylaxis This very possible combo would demonstrate rapid and durable efficacy, consistency across induction regimens, competitive tolerability, and perhaps most importantly—the ability to dramatically reduce dosing frequency without meaningful weight regain. Maintenance h
View on X ↗